1. The Sydney Multicentre Study of Parkinson's disease: a report on the first three years;Hely, M.A.; Morris, J.G.L.; Rail, D.;J Neurol Neurosurg Psychiatry,1989
2. Calne DB, Teychenne PF, Claveria LE, et al. Bromocriptine in Parkinson's disease. BMJ 1974;4:442-4.
3. Comparative pharmacokinetic investigation with tritium-labelled ergot alkaloids after oral and intravenous administration to man;Aellig, W.H.; Nuesch, E.;Int J Clin Pharmacol,1977
4. Bromocriptine in Parkinsonism: long-term treatment, dose response and comparison with levodopa;Parkes, J.D.; Debono, A.G.; Marsden, C.D.;J Neurol Neurosurg Psychiatry,1976
5. Sustained bromocriptine therapy in 50 previously untreated patients with Parkinson's disease;Stern, G.M.; Lees, A.J.;Adv Neurol,1983